low-intensity chemotherapy (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for low-intensity chemotherapy (unspecified), covering 2022-11-04 to 2022-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]